fbpx
April 4, 2022

FDA Approves Leadless, Single-Chamber Pacemaker System FDA Approves Leadless, Single-Chamber Pacemaker System

The Food and Drug Administration has granted approval to Abbott’s Aveir leadless, single-chamber pacemaker system for patients with bradycardia. In a press release, Abbott said the device […]
April 4, 2022

Urologic Scopes Recalled Over Contamination Fears Urologic Scopes Recalled Over Contamination Fears

Karl Storz is recalling more than two dozen models of its urological endoscopes over concerns that the devices may not be adequately cleaned using instructions from […]
April 4, 2022

FDA Approves Software to Semiautomate Anesthesia Delivery FDA Approves Software to Semiautomate Anesthesia Delivery

The US Food and Drug Administration (FDA) has approved the first software to semiautomate anesthesia delivery during surgery. The software, End-tidal (Et) Control, works with General […]
March 29, 2022

FDA Okays New Med for Lennox-Gastaut Syndrome FDA Okays New Med for Lennox-Gastaut Syndrome

The US Food and Drug Administration (FDA) has approved fenfluramine (Fintepla) oral solution, a Schedule IV controlled substance, for the treatment of seizures associated with Lennox-Gastaut […]
March 29, 2022

FDA Okays Semaglutide Higher Dose, 2 mg/Week, for Type 2 Diabetes FDA Okays Semaglutide Higher Dose, 2 mg/Week, for Type 2 Diabetes

The US Food and Drug Administration has approved a higher 2-mg dose of the GLP-1 agonist semaglutide (Ozempic, Novo Nordisk) for adults with type 2 diabetes, […]
March 29, 2022

FDA Approves Cabenuva Initiation Without Oral Lead-in FDA Approves Cabenuva Initiation Without Oral Lead-in

Initiating treatment may become easier for adults living with HIV. The US Food and Drug Administration has approved a label update that allows adults living with […]
March 24, 2022

FDA Approves New Radioligand Therapy and Diagnostic for mCRPC FDA Approves New Radioligand Therapy and Diagnostic for mCRPC

The US Food and Drug Administration (FDA) has approved a new radioligand treatment for certain men with metastatic castration-resistant prostate cancer (mCRPC), as well as a […]
March 22, 2022

Pfizer Recalls BP Drugs Because of Potential Carcinogen Pfizer Recalls BP Drugs Because of Potential Carcinogen

Pfizer is voluntarily recalling some antihypertensive medications because of unacceptable levels of a potential carcinogen, the company announced.  The affected products are quinapril HCI/hydrochlorothiazide (Accuretic) tablets that Pfizer distributes, […]
March 19, 2022

FDA Approves New Immunotherapy Combo for Melanoma FDA Approves New Immunotherapy Combo for Melanoma

The FDA tonight approved a combination nivolumab/relatlimab-rmbw immune checkpoint inhibitor (Opdualag) for unresectable or metastatic melanoma in adults and children 12 years or older, according to […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0